Human medicines European public assessment report (EPAR): Xolair, omalizumab, Date of authorisation: 25/10/2005, Revision: 52, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 28 May 2025 - 16:21

Human medicines European public assessment report (EPAR): Xolair, omalizumab, Date of authorisation: 25/10/2005, Revision: 52, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/xolair

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters